Thomas John Semrad

1.4k citations
41 papers · 1k · 1 hit paper · h-index 14

Impact in

    • Venous Thromboembolism Diagnosis and Management
  • Oncology top 10%
    • Cancer Immunotherapy and Biomarkers
    • Pancreatic and Hepatic Oncology Research

Papers in

    • Colorectal Cancer Treatments and Studies 5
    • Pancreatic and Hepatic Oncology Research 3
    • Cancer Treatment and Pharmacology 3
    • Lung Cancer Treatments and Mutations 3
    • Gastric Cancer Management and Outcomes 3

Thomas John Semrad

40 papers receiving 980 citations

Thomas John Semrad's Hit Papers

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline 2023 · 149 citations
1490+1+2Years since publication4080120

Peers

Thomas John Semrad
Comparison fields: 5 of 69
  • Internal Medicine 142
  • Oncology 237
  • Otorhinolaryngology 58
  • Genetics 65
  • Pulmonary and Respiratory Medicine 180
Replace Heinz Josef Lenz with:
Heinz Josef Lenz United States
Dong‐Hoe Koo South Korea
C. Oberhoff Germany
Wilfried J. Graveland Netherlands
Roberto Moretto Italy
Ana Custodio Spain
Federica Cuppone Italy
Melanie Mackean United Kingdom
Yuan-Hong Gao China
Constantijne Helene Mom Netherlands
Thomas John Semrad relative to Heinz Josef Lenz United States Heinz Josef Lenz's profile →
Citations per field
00.5×5×10.8×
Heinz Josef Lenz · 1×
Citations per year

Countries citing papers authored by Thomas John Semrad

Since Specialization
Citations

This map shows the geographic impact of Thomas John Semrad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas John Semrad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas John Semrad more than expected).

Fields of papers citing papers by Thomas John Semrad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas John Semrad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas John Semrad. The network helps show where Thomas John Semrad may publish in the future.

Co-authors

The 25 scholars most cited alongside Thomas John Semrad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas John Semrad Line = papers co-authored together Thomas John Semrad links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2007229
2
Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline
Hit paper breakdown →
2023149
3 201578
4 201766
5 201963
6 201137
7 201136
8 201428
9 201626
10 201825
11 201421
12 202021
13 201515
14 201815
15 201514
16 201714
17 201513
18 201312
19 202112
20 201111

About Thomas John Semrad

Thomas John Semrad is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism, Cell Biology and Molecular Biology, having authored 41 papers that have together received 1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (5 papers), Thyroid Cancer Diagnosis and Treatment (4 papers), Lung Cancer Treatments and Mutations (3 papers), Microtubule and mitosis dynamics (3 papers), Cancer therapeutics and mechanisms (3 papers), Pancreatic and Hepatic Oncology Research (3 papers), Cancer Treatment and Pharmacology (3 papers) and Gastric Cancer Management and Outcomes (3 papers). The work is most often cited by research in Internal Medicine (142 citations), Oncology (237 citations), Otorhinolaryngology (58 citations), Genetics (65 citations) and Pulmonary and Respiratory Medicine (180 citations). Thomas John Semrad has collaborated with scholars based in United States, Japan and Canada. Frequent co-authors include Danielle Jenine Harvey, Robert T. OʼDonnell, Philip C. Mack, Helen K. Chew, Hong Zhou, Richard H. R. White, Ted Wun, David R. Gandara, Primo N. Lara and Karen L. Kelly. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Clinical Lung Cancer, Clinical Immunology and Thyroid.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact